Riskpilot← Back to searchSign inGet full accessNikouMed AB
ABActiveOrg 5591019459Dalgårdsvägen 27General medical practice activities · NACE 8621Est. 20171 employees
Revenue 2024
SEK -1
-100% vs 2023
EBITDA margin
519900.0%
-108% vs 2023
Equity ratio
97.3%
Financial strength
Net profit 2024
SEK -3K
-105% vs 2023
| Revenue | SEK -1 | -100% |
| EBITDA | SEK -5K | -108% |
| Net profit | SEK -3K | -105% |
| Total assets | SEK 92K | -54% |
| Equity | SEK 90K | -47% |
| Employees | 1 | — |
Legal name
NikouMed AB
Org number
5591019459
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
23 februari 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva hälso-, frisk- och sjukvårdsverksamhet samt forskning, föreläsningar och egen mottagningsverksamhet. Framtagande av utbildnings- och undervisningsmaterial samt utbildning, utveckling och rådgivningsverksamhet. Bemanning, personaluthyrning, läkarkonsultationer. Utföra kosmetiska behandlingar.
Address
Dalgårdsvägen 27
Email
alex.nikou@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 135 | 145 | 130 | −0 |
| Staff expenses | — | — | −48 | −15 | −0 |
| EBITDA | −115 | −23 | 40 | 63 | −5 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −115 | −23 | 40 | 63 | −5 |
| Net financials | — | — | 0 | 1 | 2 |
| Profit before tax | −115 | −23 | 40 | 64 | −3 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −115 | −23 | 40 | 64 | −3 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 118 | 88 | 129 | 201 | 92 |
| Equity | 17 | 64 | 105 | 168 | 90 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 102 | 24 | 25 | 32 | 3 |
| Total debt | 102 | 24 | 25 | 32 | 3 |
EBITDA margin
-519900.0%
This company
15.8%
Market median
-3290606% vs market
20202024
Equity ratio
97.3%
This company
38.2%
Market median
+155% vs market
20202024
Return on equity
-3.7%
This company
18.4%
Market median
-120% vs market
20202024
Net profit margin
-334300.0%
This company
8.1%
Market median
-4127260% vs market
20202024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NikouMed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Shahrzad Ashkani | Deputy Board Member | 0 companies |
| Alexander Nikou | Board of Directors | 0 companies |